Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

8.09
Delayed Data
As of Jul 28
 +0.43 / +5.61%
Today’s Change
7.29
Today|||52-Week Range
18.48
-42.83%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line-28.1M-25.4M-46.7M-111.5M
 
 
 
 
 
Depreciation47.0K35.0K54.0K306.0K
 
 
 
 
 
Total Other Cash Flow1.8M2.2M5.9M27.0M
 
 
 
 
 
Funds From Operations-26.2M-23.2M-40.8M-83.6M
 
 
 
 
 
Funds From/For Other Operating Expenses-3.4M1.6M-6.5M-2.6M
 
 
 
 
 
Net Cash Flow - Operating Activities-22.8M-24.8M-34.3M-81.0M
 
 
 
 
 
 
InvestingIncrease In Investments-9.9M-11.3M-24.4M-49.8M
 
 
 
 
 
Decrease In Investments5.8M15.5M24.4M38.3M
 
 
 
 
 
Capital Expenditures-57.0K-24.0K-346.0K-1.5M
 
 
 
 
 
Net Cash Flow Investing-4.2M4.2M-346.0K-13.0M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale33.8M0.0075.7M112.6M
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing33.8M0.0075.7M112.6M
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash--0.000.000.00--
 
Net Change In Cash6.8M-20.6M41.0M18.6M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account